Ardelyx, Inc.
NASDAQ:ARDXBiotechnology
Healthcare
$3.06 -1.03%
-$0.06 today
- Market cap
- $769.20M
- Beta
- 0.58
- P/E (TTM)
- -24.5
- EPS (TTM)
- -$0.24
52W Low $3.49High $8.40
Volume 3.39M
Average 3.58M
Balance Sheet
Inspect the capital base behind the business.
Assets
$501.60M
FY 2025 · Annual
+15.1% YoYLiabilities
$334.65M
FY 2025 · Annual
+27.5% YoYEquity
$166.95M
FY 2025 · Annual
-3.7% YoYBalance Sheet
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 72.43M | 96.14M | 21.47M | 64.93M | 68M |
| Short-term Investments | 44.26M | 27.77M | 162.83M | 185.17M | 196.69M |
| Net Receivables | 502K | 7.73M | 22.03M | 57.71M | 71.85M |
| Inventory | 0 | 3.28M | 12.45M | 21.17M | 17.74M |
| Other Current Assets | 1 | 5.11M | 8.41M | 11.1M | 13.57M |
| Total Current Assets | 133.65M | 153.6M | 246.11M | 356.45M | 382.32M |
| Property, Plant & Equipment (Net) | 15.11M | 10.52M | 6.6M | 3.88M | 6.98M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.15M | 25.95M | 44.87M | 75.43M | 112.31M |
| Total Non-current Assets | 16.26M | 36.46M | 51.47M | 79.3M | 119.29M |
| Total Assets | 149.91M | 190.07M | 297.58M | 435.75M | 501.6M |
| Account Payables | 4.28M | 10.86M | 11.14M | 16M | 19.24M |
| Short-term Debt | 32.26M | 26.71M | 0 | 0 | 1.48M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 4.21M | 7.18M | 10.69M | 1.21M |
| Other Current Liabilities | 1.24M | 10.09M | 15.04M | 21.48M | 66.69M |
| Total Current Liabilities | 52.82M | 65.6M | 50.39M | 77.83M | 88.61M |
| Long-term Debt | 0 | 0 | 49.82M | 150.85M | 206.48M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 9.03M | 8.64M | 7.23M | 39.58M |
| Other Non-current Liabilities | 4.73M | 11.25M | 20.18M | 25.53M | (3.64M) |
| Total Non-current Liabilities | 14.48M | 26.13M | 80.37M | 184.64M | 246.05M |
| Total Liabilities | 67.3M | 91.74M | 130.76M | 262.47M | 334.66M |
| Common Stock | 13K | 20K | 23K | 24K | 24K |
| Retained Earnings | (712.93M) | (780.14M) | (846.2M) | (885.34M) | (946.94M) |
| Accumulated OCI | (6K) | (54K) | 224K | 57K | 198K |
| Other Stockholders Equity | (0) | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 82.62M | 98.33M | 166.82M | 173.29M | 166.95M |
| Total Debt | 45.5M | 36.46M | 55.98M | 153.44M | 211.6M |
| Net Debt | (26.92M) | (59.68M) | 34.51M | 88.51M | 143.6M |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $31.2M |
| Short-term Investments | $206.9M |
| Receivables | $82.8M |
| Inventory | $22.7M |
| Other Current | $38.2M |
| Total Current Assets | $381.9M |
| PP&E (Net) | $6.4M |
| Other Non-current | $116.2M |
| Total Non-current Assets | $122.6M |
| Total Assets | $504.5M |
Analysis
Selected assets total $504.5M for Latest. The largest visible component is Short-term Investments at $206.9M, about 41.0% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 3, 2026 | |
| 8-K | Current report | Nov 3, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 25, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 25, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 25, 2026 |
How much cash does ARDX have?
Ardelyx, Inc. (ARDX) reported $68.00M in cash and equivalents in fiscal 2025.
How much debt does ARDX carry?
Ardelyx, Inc. (ARDX) reported $211.59M of total debt, with net debt of $143.60M.
Continue the stock analysis
Jump to another research area for this company.